Direct stimulation of bone resorption by epidermal growth factor

Area of Science:

• Bone biology and endocrinology
• Cellular signaling pathways
• Biochemistry of growth factors

Background:

• Bone resorption is a critical process in skeletal remodeling.
• Epidermal growth factor (EGF) and fibroblast growth factor (FGF) are known signaling molecules.
• The role of EGF and FGF in bone resorption requires further elucidation.

Purpose of the Study:

• To investigate the direct effects of mouse EGF (mEGF), human EGF (hEGF), and FGF on bone resorption.
• To determine the involvement of prostaglandin synthesis in EGF-mediated bone resorption.

Main Methods:

• Cultured fetal rat long bone shafts were used to measure 45Ca release.
• Effects of varying concentrations of mEGF, hEGF, and FGF were assessed.
• Inhibition of prostaglandin synthesis was tested using specific blocking agents.

Main Results:

• mEGF and hEGF significantly stimulated bone resorption in a dose-dependent manner.
• EGF-induced resorption was not blocked by prostaglandin synthesis inhibitors.
• FGF did not stimulate bone resorption even at high concentrations.
• Neither EGF nor FGF altered prostaglandin E levels in the culture medium.

Conclusions:

• EGF is a direct stimulator of bone resorption, distinct from FGF.
• The mechanism of EGF-induced bone resorption is independent of prostaglandin synthesis.
• Human EGF found in urine may contribute to calcium-mobilizing activity in urine concentrates.